look at their share price nowonly about one third of what it was when we were discussing the possibility of IVA bidding for the 80% of EXS that it did not own at the time
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025